BIOCON : Malaysian MoH extends Biocon Biologics' insulin supply contract by 6 months.
Biocon's Malaysian arm and partner Duopharma received a 6-month extension (Apr 29–Oct 28, 2025) to the existing 3-year insulin supply contract.
Biocon has served Malaysia's Ministry of Health (MoH) for nearly 10 years with insulin products.
Insulins are manufactured at Biocon's Johor facility and distributed via Duopharma.
Contract formalisation pending through a supplementary agreement.
Biocon reiterated its commitment to affordable insulin access in Malaysia and globally.
Biocon's Malaysian arm and partner Duopharma received a 6-month extension (Apr 29–Oct 28, 2025) to the existing 3-year insulin supply contract.
Biocon has served Malaysia's Ministry of Health (MoH) for nearly 10 years with insulin products.
Insulins are manufactured at Biocon's Johor facility and distributed via Duopharma.
Contract formalisation pending through a supplementary agreement.
Biocon reiterated its commitment to affordable insulin access in Malaysia and globally.
